Gene · 81029
WNT5B: Wnt family member 5B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. WNT5B: Wnt family member 5B. Genes, record 81029. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/81029
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9H1J7 | Protein Wnt-5b | 359 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents95
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 4582 | Q9H1J7 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14313 | Q9H1J7 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14314 | Q9H1J7 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14315 | Q9H1J7 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 8087 | Q9H1J7 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 8087 | Q9H1J7 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4582 | Q9H1J7 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14313 | Q9H1J7 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14314 | Q9H1J7 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14315 | Q9H1J7 | Espacenet |
1 to 10 of 95
See all 95 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,200
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | WNT5B papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30DK017047 | Diabetes Research Center | 3 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 3 | 2025 |
| P50CA116201 | Mayo Clinic Breast Cancer SPORE | 3 | 2025 |
| R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 3 | 2025 |
| R01AR047364 | Epigenetic Regulation of Skin Regional Specificity | 3 | 2025 |
| R01LM012806 | Predicting Phenotype by Deep Learning Heterogeneous Multi-Omics Data | 3 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
1 to 10 of 1,200Source NIH's project files
See all 1,200 nih grantsPapers1,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Propofol-Induced Metabolic, Apoptotic, and Wnt-Frizzled-Related Transcript Changes in MIA PaCa-2 Cells: In Vitro and Bioinformatic Analyses. | Curr Issues Mol Biol | 2026 | 42793306 | PubTator, text mining | PubMed |
| Key regulatory elements of the TGFβ-LRRC15 axis predict disease progression and immunotherapy resistance across cancer types. | Proc Natl Acad Sci U S A | 2026 | 42771495 | PubTator, text mining | PubMed |
| IGFBP5 alleviates periodontitis by reversing human dental follicle stem cell senescence via the non-canonical Wnt pathway. | Int J Oral Sci | 2026 | 42736271 | PubTator, text mining | PubMed |
| miR-486-3p Suppresses Malignant Phenotypes and is Associated with Reduced WNT5B, DVL1, and β-catenin Expression in Lung Adenocarcinoma Cells. | J Vis Exp | 2026 | 42631613 | PubTator, text mining | PubMed |
| A Combination of Variants in SEPTIN9 and MSX1 Genes Leads to the Formation of Orofacial Clefts. | Genes Cells | 2026 | 42429105 | PubTator, text mining | PubMed |
| Role of the Wnt5A pathway in resistance to immune checkpoint inhibitors in advanced Non-Small Cell Lung Cancer. | Cancer Immunol Immunother | 2026 | 42178414 | PubTator, text mining | PubMed |
| The Regulation and Function of Hippo/YAP Pathway in Cancer. | FASEB J | 2026 | 41924992 | PubTator, text mining | PubMed |
| Therapeutic Activities of Multipotent Stromal Cells for Islet Regeneration. | Cells | 2026 | 41892279 | PubTator, text mining | PubMed |
| Snapshot on Cell-to-Cell Communication Nanotubes: From Bacteria to Humans. | Biology (Basel) | 2026 | 41892274 | PubTator, text mining | PubMed |
| Giant cell tumor of bone inhibits osteoblastogenesis via WNT5B. | J Bone Miner Metab | 2026 | 41872383 | PubTator, text mining | PubMed |
1 to 10 of 1,405
See all 1,405 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/81029
GET https://conductscience.org/api/genes/v1/81029/patents?page=2